China Pharma Holdings (CPHI) EV to FCF (2010 - 2026)

China Pharma Holdings (CPHI) has reported EV to FCF for 17 consecutive years, with 805.4 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to FCF fell 4338.2% year-over-year to 805.4; the trailing twelve-month figure through Jun 2026 stood at 186.78 (down 1475.13% YoY), and the FY2025 full-year result was 54.51, up 805.59% from the prior year.
• EV to FCF retreated to 805.4 in Q2 2026 per CPHI's latest filing, from 279.38 in the prior quarter.
• Across five years, EV to FCF topped out at 31.99 in Q4 2025 and bottomed at 805.4 in Q2 2026.
• Historically, EV to FCF has averaged 81.3 across 5 years, with a median of 16.77 in 2022.
• The sharpest annual moves came in 2024 and 2025: EV to FCF tumbled 14979.6% in 2024, then surged 160.16% in 2025.
• Over 5 years, EV to FCF stood at 4.92 in 2022, then slumped by 571.62% to 23.21 in 2023, then surged by 152.98% to 12.3 in 2024, then soared by 160.16% to 31.99 in 2025, then plunged by 2617.72% to 805.4 in 2026.
• According to Business Quant data, EV to FCF over the past three periods registered 805.4, 279.38, and 31.99 for Q2 2026, Q1 2026, and Q4 2025 respectively.